We are live on ! Find out more

2,990 hedge funds and large institutions have $163B invested in Merck in 2022 Q3 according to their latest regulatory filings, with 121 funds opening new positions, 1,374 increasing their positions, 1,114 reducing their positions, and 104 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more call options, than puts

Call options by funds: $2.42B | Put options by funds: $1.79B

23% more repeat investments, than reductions

Existing positions increased: 1,374 | Existing positions reduced: 1,114

16% more first-time investments, than exits

New positions opened: 121 | Existing positions closed: 104

0.78% more ownership

Funds ownership: 74.29%75.08% (+0.78%)

1% less funds holding

Funds holding: 3,0142,990 (-24)

4% less capital invested

Capital invested by funds: $171B → $163B (-$7.45B)

6% less funds holding in top 10

Funds holding in top 10: 238224 (-14)

Holders
2,990
Holders Change
-24
Holders Change %
-0.8%
% of All Funds
51.5%
Holding in Top 10
224
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.88%
% of All Funds
3.86%
New
121
Increased
1,374
Reduced
1,114
Closed
104
Calls
$2.42B
Puts
$1.79B
Net Calls
+$627M
Net Calls Change
+$85.4M
Name Holding Trade Value Shares
Change
Change in
Stake
WAP
1126
Wealthcare Advisory Partners
Pennsylvania
$3.25M +$634K +7,105 +23%
SCM
1127
Schnieders Capital Management
California
$3.24M +$674K +7,550 +25%
JAG
1128
Journey Advisory Group
Kentucky
$3.24M -$23.8K -267 -0.7%
ONSWM
1129
Old North State Wealth Management
North Carolina
$3.24M -$453K -5,079 -12%
AOWM
1130
Alpha Omega Wealth Management
Virginia
$3.23M -$102K -1,139 -3%
SFG
1131
SNS Financial Group
Minnesota
$3.23M -$13.1K -147 -0.4%
CA
1132
CoreCap Advisors
Michigan
$3.22M +$2.81M +31,492 +531%
BP
1133
Ballentine Partners
Massachusetts
$3.21M +$348K +3,897 +12%
BCA
1134
Bay Colony Advisors
Massachusetts
$3.21M +$172K +1,925 +5%
CPO
1135
Cerity Partners OCIO
New York
$3.19M +$192K +2,156 +6%
GC
1136
Gould Capital
Washington
$3.19M -$22.9K -257 -0.7%
PAM
1137
Paradigm Asset Management
New York
$3.19M -$26.8K -300 -0.8%
SC
1138
Searle & Co
Connecticut
$3.18M
DIP
1139
DT Investment Partners
Pennsylvania
$3.17M -$295K -3,299 -8%
FFA
1140
First Foundation Advisors
California
$3.17M +$488K +5,468 +17%
MPM
1141
Meritage Portfolio Management
Kansas
$3.17M +$206K +2,303 +7%
TA
1142
Tectonic Advisors
Texas
$3.13M +$413K +4,624 +15%
AIM
1143
Allen Investment Management
New York
$3.13M
SCA
1144
Stokes Capital Advisors
South Carolina
$3.12M -$1.22M -13,718 -27%
WPW
1145
Waldron Private Wealth
Pennsylvania
$3.12M +$89.2K +999 +3%
HCA
1146
Harbour Capital Advisors
Virginia
$3.12M -$14.7K -165 -0.5%
SW
1147
SlateStone Wealth
Florida
$3.12M +$27.2K +305 +0.8%
PFM
1148
Premier Fund Managers
United Kingdom
$3.12M -$11M -122,700 -77%
SFP
1149
Shepherd Financial Partners
Massachusetts
$3.12M -$495K -5,545 -13%
WIS
1150
Wright Investors Service
Connecticut
$3.11M +$347K +3,882 +12%

MRK Hedge Fund Activity: Q3 2022 in Review

2,990 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2022, worth a combined $163B — down 4.4% from $171B a quarter earlier.

Buyers outnumbered sellers: 121 funds opened new MRK positions and 104 closed out — a net gain of 17 holders — while 1,374 added to existing stakes and 1,114 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $1.47B. The largest seller was Marshall Wace, cutting an estimated $459M.

  • 2,990 institutional investors held Merck (MRK) as of Q3 2022, down from 3,014 in Q2 2022.
  • Funds reported $163B of Merck stock for Q3 2022, down 4.4% quarter-over-quarter.
  • 121 funds opened new Merck positions in Q3 2022 and 104 closed out, a net change of +17 holders.
  • The largest Merck buyer in Q3 2022 was Janus Henderson Group, an estimated $1.47B added.
  • The largest Merck seller in Q3 2022 was Marshall Wace, an estimated $459M sold.

Based on aggregated 13F filings for Q3 2022.